The facile synthesis and in vitro activity of a library of heavy atom-free BODIPY-anthracene, -pyrene dyads (BAD-13-BPyrD-19) and a control (BODIPY 20) are reported. We demonstrate that singlet oxygen produced from dyad triplet states formed from charge-separated states is sufficient to induce cytotoxicity in human breast cancer cells (MDA-MB-468) at micromolar concentrations. The compounds in this series are promising candidates for photodynamic therapy, especially BAD-17 which displays significant photocytotoxicity (15% cell viability) at a concentration of 5 × 10 -7 M, with minimal toxicity (89% cell viability) in the absence of light. Savoie, H.; Boyle, R. W.; Senge, M. O. (2019):
Introduction
Photodynamic therapy (PDT) exploits the relationship between light of a specific wavelength, ground state triplet oxygen and a photoactive molecule to deliver a cytotoxic response mediated by singlet oxygen and other reactive oxygen species. [1] However, major drawbacks restrict the widespread application of PDT in clinical settings. These include, but are not limited to, photosensitivity post treatment, biocompatibility and large scale production of the photoactive molecule, and the development of photosensitizers with longlived triplet states. Still, the phenomenon of photosensitization is universally studied and has been utilized in biomedical applications for centuries, [1a,2] and in recent decades BODIPY (boron-dipyrromethene)-based systems have established themselves as feasible agents for both phototherapy and diagnostics. [3] Moreover, the design of systems in which singlet oxygen generation can be modulated by different stimuli is also of increasing interest in the PDT community. [4] Inherently, BODIPYs are chromophores, and therefore populate excited singlet states upon absorption of light. [5] Common design strategies employed to enhance intersystem crossing (ISC), and thus population of longer lived excited triplet states from which singlet oxygen is generated include halogenation, [6] dimerization [7] and conjugation to a spin converter e.g., C 60 [8] (Fig. 1, compounds 1, 2 and 4) . Additionally, aza-BODIPYs have been extensively studied for applications in PDT due to their red-shifted absorption spectra. Compound 3 is a highlight, both in vitro and in vivo, of the BODIPY-based PDT field with a reported 71% ablation of mammary tumors in a mouse model. [9] Our group has experience in the design and optimization of singlet oxygen sensitizers. Recently, we reported a family of BODIPY-anthracene, -pyrene and -perylene dyads (BAD, BPyrD) which produce triplet states via charge-separated states [10] generated by photo-induced electron transfer (PeT, Fig. 2 and Fig. 3 ). [11] We investigated the singlet oxygen quantum yields of these compounds, the most efficient being 67% in ethanol ( Fig. 3 , Table 1 ). Some of these exhibit a unique dual performance in triplet-triplet annihilation photon upconversion (TTA-UC), either as a sensitizer or emitter component. [12] We propose that these compounds have characteristics fundamental to PDT photosensitizers. Firstly, PeT is enhanced in polar media due to stabilization of the charge-separated state, providing a singlet oxygen-generating mechanism ( Table  1) that can be modulated. [10b,c] Moreover, as PeT is in competition with fluorescence, real time imaging of oxidative stress is possible. [10a] These compounds are heavy atom-free, unlike other BODIPY chromophores suitable for PDT, and are expected to show high light/dark cytotoxicity ratios, similar to those observed in our previous test case. [10a] These compounds are also synthetically accessible and suitable for large scale production via acid-catalyzed condensation between the aryl aldehyde and either 2-methylpyrrole or 2,4-dimethylpyrrole, oxidation using DDQ and boron insertion to yield the BODIPY in a one pot reaction. [10a] However, the parent BODIPYs are themselves insoluble in biological media and thus modification is required to realize their potential as PDT agents.
Results and discussion
In this body of work we translate our previous studies by providing a library of eight water-soluble compounds BAD-13-BPyrD-19 and a control (BODIPY 20) . To ascertain their applicability to PDT we have included in vitro evidence of cytotoxicity. The activity under biological conditions is presented and compared with singlet oxygen quantum yields of the parent and water-soluble BODIPYs in ethanol. Firstly, we selected the parent BODIPYs with promising singlet oxygen quantum yields in polar solvents ( Table 1 ) and synthesized them as previously described. We then introduced water-solubility using a two-step approach. Fluorine substitution with N,N-dimethylaminopropyne-1 units was followed by quaternization of the dimethylamino group with 1,3-propanesultone, which precipitated from the non-polar solvent, to afford compounds BAD-13-BPyrD-19, containing zwitterionic fragments that introduced water solubility ( Fig. 4 , Scheme 1). [13] For the cell biological studies, a control, 20, bearing a phenyl group that cannot undergo the PeT process to produce singlet oxygen due to incompatible molecular orbital energies, was included ( Fig. 4 , Scheme 1). The series of water-soluble dyads were synthesized with substitution yields between 50-74% and quaternization yields between 45-94% ( Fig. 4 ). Scheme 1 General synthesis of water-soluble dyads. (a) 1. 3-Dimethylamino-1-propyne (4.5 eq.), n-BuLi (4 eq.), THF, rt, 30 min. 2. BAD, THF, rt, 2 h; (b) 1,3-propanesultone (6 eq.), EtOAc, 80 °C, 2 h. All parent and water-soluble BODIPYs synthesized are described in Fig. 3 and Fig 4. , respectively.
Normalized absorption spectra for compounds BAD-13compound 20 in water and ethanol are shown in Fig. 5 . The two distinct units are evident with the anthracene or pyrene absorption maxima between 326 and 400 nm and the BODIPY unit absorbing between 501 and 527 nm ( Table 2 ). The absorbance of anthracene is red-shifted compared to that of pyrene due to it having a smaller HOMO-LUMO gap.
[10b] The compounds do not display significant changes in absorption maxima between the solvents, however a larger full width at half maxima is seen in water compared to ethanol due to the relative solvent polarity ( Fig. 5 ).
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Please do not adjust margins The fluorescence spectra and quantum yields are shown in Fig.  6 and Table 2 . The quantum yields of the compounds were measured relative to the fluorescence of fluorescein in 0.1 M NaOH (φ f = 0.95) and at a concentration of 1 × 10 -5 M. [14] BAD-13-BPyrD-19 display low fluorescence in both ethanol and water (<5%). This is expected as the PeT mechanism is in competition with fluorescence ( Fig. 2) . In contrast compound 20 displays relatively high fluorescence in both water and ethanol, 19% and 22% respectively, indicating that the triplet state is not as readily populated. We also observe lower fluorescence quantum yields in water compared to ethanol, due to the charge-separated state being stabilized to a greater extent in the more polar solvent. The same trend is not observed in BAD-20, which does not generate a charge-separated state ( Fig. 6 and Table 2 ).
We then undertook singlet oxygen quantum yield studies of the water-soluble derivatives, BAD-13-BPyrD-19 and a control (BODIPY 20) in water (Table 3) , using a protocol adopted from literature (see SI). [15] Overall, they show comparable singlet oxygen quantum yields to that of the parent BODIPYs (BAD- [5] [6] [7] [8] [9] [10] [11] [12] . Notably, control 20 displays negligible singlet oxygen generating abilities, as expected.
Figure 6
Emission spectra for compounds BAD-13-20 in water (red) and ethanol (black). The quantum yields of the compounds were measured relative to the fluorescence of fluorescein in 0.1 M NaOH (φf = 0.95) and at a concentration of 1 × 10 -5 M. [14] To determine if photocytotoxicity could be observed, human breast cancer (MDA-MB-468) cells were incubated with compounds BAD-13-20 at various concentrations (8 × 10 -4 -5 × 10 -8 M) for 1 h. Following this, they were irradiated with broad-band visible light (400−700 nm, 23.8 mW cm −2 ). The cells were then returned to the incubator for 24 h and an MTT assay was performed to determine cell viability (Fig. 7) . [16] LC50 values were then calculated ( Table 4 ).
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Please do not adjust margins BAD-13 and BAD-14 have previously been investigated [10a] and are included as standards in this study. BAD-6 has higher singlet oxygen quantum yield in ethanol (67%) when compared with BAD-5 (38%). Similarly, BAD-14 has a higher singlet oxygen quantum yield in ethanol (52%) when compared to BAD-13 (38%) and this pattern is reflected in the in vitro studies. Although both BAD-13 and BAD-14 induced some degree of photocytotoxicity at micromolar concentrations, at the same concentration of 5 × 10 -6 M the cell viability was reduced from 96% under dark conditions to 47% following illumination for BAD-14 but there was a negligible reduction for BAD-13 (Fig. 7) . The LD 50 values for BAD-13 and BAD-14 are 8.7 × 10 -6 M and 6.1 × 10 -6 M, respectively (Table 4) .
BAD-15 and BAD-16 contain anthracene at the 8 position of the BODIPY, resulting in a decrease in the HOMO (highest occupied molecular orbital) energy of the donor and thus has a slower rate of PeT compared to BAD-13 and BAD-14.
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Please do not adjust margins Please do not adjust margins parent BODIPYs (BAD-7 and BAD-8) are reported to have similar singlet oxygen quantum yields in ethanol, 47% and 53%, respectively. BAD-15 has a singlet oxygen quantum yield in ethanol of 64% and BAD-16 of 39 % (Table 3) . BAD-15 performed best and showed reduction in cell viability to 3% at 2.5 × 10 -6 M (Fig. 7) and when directly compared to BAD-14 at a concentration of 1 × 10 -6 M shows improved photocytotoxicity (60% viability vs no reduction in cell viability). Additionally, BAD-15 has lower LD 50 value (1.3 × 10 -6 M) than BAD-13 and BAD-14 (Table 4) . As we previously shown, BAD-13 is able to undergo a cycloaddition reaction with self-sensitized singlet oxygen on the 9methylanthracene subunit, [10a] which, may in part account for the reduced singlet oxygen quantum yield and lower cytotoxicity observed for this dyad. On the other hand, BAD-15 and BAD-16 are based on the unsubstituted anthracene which is known to possess rather low reactivity towards singlet oxygen, providing higher photostability and sensitization efficiency for these dyads. [17] The phenylanthracene-based BODIPYs, BAD-17 and BAD-18, again show micromolar and submicromolar activities under biological conditions and the parent BODIPYs (BAD-9 and BAD-10) have similar singlet oxygen quantum yields of 46% and 59% in ethanol. BAD-17 and BAD-18 have singlet oxygen quantum yields in ethanol of 48% and 66%, respectively (Table 3) . BAD-17 has been identified as the best performing dyad of the study (LD 50 value of 2.8 × 10 -7 M, Table 4 ) with phototoxicity (89% cell viability under dark conditions vs 15% cell viability following irradiation) at 5 × 10 -7 M (Fig. 7) . In contrast, Fig. 7 shows that BAD-14 does not display any photocytotoxicity at this concentration. Moreover, at a concentration of 5 × 10 -6 M BAD-18 effects a more profound reduction in cell viability (15%) when compared to the standard BAD-14 (47% viability).
In addition to the anthracene derivatives, we also tested a pyrene-BODIPY dyad, BPyrD-19, which also showed cell phototoxicity and a singlet oxygen quantum yield in ethanol of only 3%. The parent BODIPY was previously shown to have a singlet oxygen quantum yield of 25% in ethanol. At a concentration of 1 × 10 -5 M there is a reduction in cell viability from 95% to 9% post illumination. At a lower concentration of 5 × 10 -6 M significant photocytotoxicity (43% viability) is also observed (Fig. 7) . The efficiency of this photosensitizer is similar to that of BAD-14, which at a dyad concentration of 5 × 10 -6 M has a reduction in cell viability to 46% following light activation (Fig. 7) .
The final compound tested was the control, 20, which did not display significant sensitization in ethanol. As seen in Fig. 7 , there is nominal photocytotoxicity at appreciable concentrations with an LD 50 value of 8.2 × 10 -4 M. However, there was a moderate decrease in cell viability (85% vs 52%) at the highest concentration of 8 × 10 -4 M when light was introduced. This would indicate that photosensitization does take place at high concentration but overall, there is minimal phototoxicity and thus PDT is in fact the predominant mechanism for cell toxicity observed in the active compounds. Importantly, this experiment also shows that the water-soluble aryl-BODIPYs are not inherently toxic at the concentrations under investigation.
Conclusions
A series of synthetically accessible heavy atom-free watersoluble aryl-BODIPY photosensitizers were synthesized using condensation, fluorine substitution and quaternization reactions. Extensive in vitro analysis was performed and we have shown varying photocytotoxicity efficiencies resulting from singlet oxygen produced via a PeT mechanism. The cytotoxicity studies show that all active compounds cause a reduction in cell viability after illumination and minimal dark toxicity ( Fig. 7 and Table 4 ). These light-to-dark ratios are an important property for the development of successful photosensitizers as they contribute to tackling generalized photosensitivity which plagues current PDT regimes. [18] Although the singlet oxygen quantum yields of the watersoluble BODIPYs in ethanol cannot fully account for the in vitro activities as factors including cell uptake have not been considered in the present study, we see similar patterns of toxicity that are consistent with the synthetic tunability of this family of compounds. This is further validated by the negligible activity of the control compound, 20, in vitro. The control experiment as well as the light-to-dark ratios has also consolidated that the water-soluble aryl-BODIPYs do not have inherent toxicity and that singlet oxygen generation is the predominant mechanism of action.
We have shown that three BADs (BAD-15, BAD-17, BAD-18) have higher toxicity in comparison to the standard, BAD-14 (LD 50 value = 6.1 × 10 -6 M). In particular, the submicromolar activity of BAD-17 (LD 50 value = 2.8 × 10 -7 M) is significantly more potent than BAD-14. This enhancement has considerable consequences for photosensitizer dosage. Coupled with the compounds low light-to-dark toxicity ratios, long-lived triplet state and synthetic accessibility makes it a target for future exploration. We intend to continue the development of this class of photosensitizer with cell uptake and localization studies, in vivo studies and by optimizing our compounds to feature more red-shifted absorption spectra.
Experimental

Materials and Methods
Unless otherwise specified, all chemicals including 10methylanthracene-9-carboxaldehyde, anthracene-9-carbaldehyde, benzaldehyde, pyrene-1-carboxaldehyde and 2,4-dimethylpyrrole were sourced commercially and used without further purification. The synthetic procedures were adapted from literature and characterized accordingly as follows: 3,5-dimethyl-8-(10methylanthracen-9-yl)-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene, BAD-5, [10a] 1,3,5,7-tetramethyl-8-(10-methylanthracen-9-yl)-4,4difluoro-4-bora-3a,4a-diaza-s-indacene, BAD-6, [19] 3,5-dimethyl-8-(10-methylanthracen-9-yl) -4,4-(3-(dimethylamino) prop-1-yn-1-yl)-4bora-3a,4a-diaza-s-indacene, BAD-21, 1,3,5,7-tetramethyl-8-(10methylanthracen-9-yl)-4,4-(3-(dimethylamino) prop-1-yn-1-yl)- 3, 4diyl) bis(prop-2-yne-3,1diyl))bis(dimethylammoniumdiyl))bis(propane-1-sulfonate), BAD-13, 3,3'-(( (1,3,5,7-tetramethyl-8-(10-methylanthracen-9-yl)-4-bora-3a,4a-diaza-s-indacene-4,4-diyl) bis(prop-2-yne-3,1diyl))bis(dimethylammoniumdiyl))bis(propane-1-sulfonate), BAD-14 , [10a] 2-methylpyrrole, [20] 10-phenylanthracene-9carbaldehyde, [10c, 21] 3,5-dimethyl-8-(anthracen-9-yl)-4,4-difluoro-4bora-3a,4a-diaza-s-indacene, BAD-7, [10b] 1,3,5,7-tetramethyl-8- Please do not adjust margins Please do not adjust margins (anthracen-9-yl)-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene, BAD-8, [19] 3,5-dimethyl-8-(10-phenylanthracen-9-yl)-4,4-difluoro-4-bora-3a,4a-diaza-s-indacene, BAD-9, 1,3,5,7-tetramethyl-8-(10phenylanthracen-9-yl)-4,4-difluoro-4-bora-3a,4adiaza-s-indacene, BAD-10, [10b] 3,5-dimethyl-8-(pyrene-1-yl)-4,4-difluoro-4-bora-3a,4adiaza-s-indacene, BPhyD-11, [10c] 1,3,5,7-tetramethyl-8-(phenyl-9-yl)-4,4-difluoro-4-bora-3a ,4a-diaza-s-indacene, 12. [22] All air and/or water sensitive materials were handled using standard high vacuum techniques. Dry THF and DCM were obtained by passing through alumina under N 2 in a solvent purification system and then further dried over activated molecular sieves. Analytical thin-layer chromatography was performed using silica gel 60 (fluorescence indicator F254, pre-coated sheets, 0.2 mm thick, 20 cm × 20 cm; Merck) plates and visualized by UV irradiation (λ = 254 nm). Column chromatography was carried out using Fluka Silica Gel 60 (230-400 mesh; Merck). UV/Vis spectra were recorded in solutions using a Specord 250 spectrophotometer from Analytic Jena (1 cm path length quartz cell). Fluorescence spectra were measured on a Cary Eclipse Fluorescence Spectrometer. NMR spectra were recorded on a Bruker AV 600, Bruker Advance III 400 MH or a Bruker DPX400 400 MHz or an Agilent 400 spectrometer. Accurate mass measurements (HRMS) were carried out using a Bruker microTOF-Q™ ESI-TOF mass spectrometer. Mass spectrometry was performed with a Q-Tof Premier Waters MALDI quadrupole time-of-flight (Q-TOF) mass spectrometer equipped with Z-spray electrospray ionization (ESI) and matrix assisted laser desorption ionization (MALDI) sources in positive mode with trans-2-[3-(4-tert-butylphenyl)-2-methyl-2-propenylidene]malononitrile as the matrix. Melting points were measured using an automated melting point machine, SMP50 (Stuart).
Synthetic procedures General Procedure A: Fluorine substitution.
To a solution of 3-dimethylamino-1-propyne (4.5 eq.) in dry THF was added n-BuLi (4 eq.). The mixture was stirred at rt for 30 min. BODIPY (1 eq.) dissolved in dry THF was added drop-wise to the reaction and the reaction was stirred at rt for 2 h. The reaction was quenched with H 2 O and concentrated. The residue was dissolved in DCM, washed with H 2 O (3 × 100 mL) and extracted with DCM (3 × 100 mL). The product was purified by silica gel column chromatography (DCM/MeOH, 10:1). General Procedure B: Sulfobetaine formation. Dimethylaminopropyne-substituted dyad (1 eq.) was dissolved in EtOAc and the solution was heated to reflux under argon. A solution of 1,3-propanesultone (6 eq.) in EtOAc (2 mL) was added and the reaction mixture was refluxed for 2 h. After cooling to rt the precipitate formed was filtered and carefully washed with Et 2 O. The obtained product was dried at 80 °C.
Experimental Detail 3,5-Dimethyl-8-(anthracen-9-yl)-4,4-(3-(dimethylamino)prop-1-yn-1-yl)-4-bora-3a,4a-diaza-s-indacene,
BAD-23: BAD-23 was synthesized in accordance with general procedure A using 3dimethylamino-1-propyne (377 mg, 4.55 mmol), dry THF (20 mL), n-BuLi (258 mg, 4.04 mmol) and BAD-7 (400 mg, 1.01 mmol) dissolved in dry THF (50 mL) to yield an orange solid (388 mg, 7.43 × 10 -4 mol, Please do not adjust margins Please do not adjust margins
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A library of heavy atom-free BODIPY-anthracene and -pyrene dyads capable of generating singlet oxygen via a PeT mechanism have been synthesized and their in vitro activity has been demonstrated.
